QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:IBB

iShares Biotechnology ETF (IBB) Price, Holdings, & News

$129.03
+0.20 (+0.16%)
(As of 06/8/2023 ET)
Compare
Today's Range
$128.23
▼
$129.31
50-Day Range
$126.17
▼
$131.92
52-Week Range
$104.29
▼
$138.74
Volume
991,756 shs
Average Volume
1.52 million shs
Market Capitalization
$7.84 billion
Assets Under Management
$7.66 billion
Dividend Yield
0.28%
Net Expense Ratio
0.44%
ProfileChartDividendInstitutional OwnershipHeadlinesHoldingsOptions ChainSEC FilingsShort InterestSocial Media
IBB stock logo

About iShares Biotechnology ETF (NASDAQ:IBB)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

IBB ETF News Headlines

May 31, 2023 | marketbeat.com
The How and Why of Investing in Biotech Stocks (IBB)
One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccines
June 8, 2023 | msn.com
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0062
June 8, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Software" to Revolutionize Warfare
This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>
May 31, 2023 | americanbankingnews.com
iShares Biotechnology ETF (NASDAQ:IBB) Sees Significant Decline in Short Interest
May 31, 2023 | msn.com
Unusual Put Option Trade in BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF (IBB) Worth $94.70K
May 11, 2023 | forbes.com
Best Biotech Stocks
May 10, 2023 | finance.yahoo.com
Biotech ETFs Pop on M&A Resurgence
April 24, 2023 | msn.com
3 Pharma Stocks That Could See a Surge in Demand in 2023
June 8, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Software" to Revolutionize Warfare
This breakthrough will change "the way wars will be fought, and won, for years to come." - Chairman of the Joint Chief of Staff, General Mark Milley Get the name of the company supplying it to the U.S. Army here >>>
April 14, 2023 | americanbankingnews.com
Investors Buy High Volume of iShares Biotechnology ETF Call Options (NASDAQ:IBB)
See More Headlines

IBB Price History

Fund Details

Issuer
iShares
Fund Name
iShares Biotechnology ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:IBB
Inception Date
2/5/2001
Fund Manager
Diane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
ICE Biotechnology Index (TR) (USD)
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
275

Fund Statistics

Assets Under Management
$7.66 billion
Average Daily Volume
$1.49 million
Discount/Premium
-0.04%

Administrator, Advisor and Custodian

Administrator
JPMorgan Chase Bank, N.A.
Advisor
BlackRock Fund Advisors
Custodian
JPMorgan Chase Bank, N.A.
Distributor
BlackRock Investments, LLC
Transfer Agent
JPMorgan Chase Bank, N.A.
Trustee
N/A
Lead Market Maker
Latour Trading

Options

Optionable
Optionable
Options Volume
5,573
Put Options
4,662
Call Options
911
Short Interest
9,370,000 shs

Miscellaneous

Outstanding Shares
60,750,000
Beta
0.84
Creation Unit
50,000
Creation Fee
$614.00


iShares Biotechnology ETF Expenses

TypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.44%0.57%0.52%0.47%0.50%
Other Expenses0.00%0.40%0.53%0.30%0.57%
Total Expense0.44%0.72%0.69%0.56%0.70%
Fee Waiver0.00%-0.50%-0.56%-0.24%-0.59%
Net Expense0.44%0.62%0.59%0.52%0.57%

iShares Biotechnology ETF (IBB) Holdings & Exposure

Top 10 IBB Holdings

IBB Sector Exposure

IBB Industry Exposure

Full Holdings Details

Key Executives

  • George G. C. Parker Ph.D.
    Independent Chairman of the Board of Trustees
  • Michael Arthur Latham
    President, Trustee
  • Jack Gee
    Chief Financial Officer, Treasurer
  • Geoffrey D. Flynn
    Chief Operating Officer, Executive Vice President

  • Bio & Compensation - 
  • Amy Schioldager
    Executive Vice President
  • Ira P. Shapiro
    Vice President, Chief Legal Officer
  • Matt Tucker
    Vice President

  • Bio & Compensation - 
  • Eilleen M. Clavere
    Secretary
  • Cecilia H. Herbert
    Independent Trustee
  • Charles A. Hurty
    Independent Trustee

Similar ETFs

Institutional Ownership

View All Institutional Transactions













IBB ETF - Frequently Asked Questions

How have IBB shares performed in 2023?

iShares Biotechnology ETF's stock was trading at $131.29 at the beginning of 2023. Since then, IBB stock has decreased by 1.7% and is now trading at $129.03.
View the best growth stocks for 2023 here.

Are investors shorting iShares Biotechnology ETF?

iShares Biotechnology ETF saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 9,370,000 shares, a decrease of 6.4% from the April 30th total of 10,010,000 shares. Based on an average daily trading volume, of 1,574,100 shares, the short-interest ratio is presently 6.0 days.
View iShares Biotechnology ETF's Short Interest.

How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?

iShares Biotechnology ETF declared a quarterly dividend on Tuesday, June 6th. Stockholders of record on Thursday, June 8th will be given a dividend of $0.0062 per share on Tuesday, June 13th. This represents a $0.02 annualized dividend and a yield of 0.02%. The ex-dividend date is Wednesday, June 7th.
Read our dividend analysis for IBB.

What does IBB invest in?

iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $7.66 billion assets under management.

What stocks does iShares Biotechnology ETF hold?

IBB invests in 275 holdings. Some of the stocks in their portfolio include Vertex Pharmaceuticals (VRTX), Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Moderna (MRNA), IQVIA (IQV), Seagen (SGEN), Illumina (ILMN) and Mettler-Toledo International (MTD).

What is the management fee for iShares Biotechnology ETF?

iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%.

When did iShares Biotechnology ETF's stock split?

iShares Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were distributed to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What other stocks do shareholders of iShares Biotechnology ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).

What is iShares Biotechnology ETF's stock symbol?

iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."

Who are iShares Biotechnology ETF's major shareholders?

iShares Biotechnology ETF's stock is owned by many different retail and institutional investors. Top institutional shareholders include Citigroup Inc. (3.32%), JPMorgan Chase & Co. (3.26%), Healthcare of Ontario Pension Plan Trust Fund (1.63%), Commerce Bank (1.21%), Proficio Capital Partners LLC (1.10%) and LPL Financial LLC (1.04%).

How do I buy shares of iShares Biotechnology ETF?

Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iShares Biotechnology ETF's stock price today?

One share of IBB stock can currently be purchased for approximately $129.03.

How much money does iShares Biotechnology ETF make?

iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $7.84 billion.

This page (NASDAQ:IBB) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -